(NASDAQ: IVF) Invo Fertility's forecast annual revenue growth rate of 55.41% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.53%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.79%.
Invo Fertility's revenue in 2026 is $6,841,250.On average, 2 Wall Street analysts forecast IVF's revenue for 2026 to be $18,794,446, with the lowest IVF revenue forecast at $18,237,203, and the highest IVF revenue forecast at $19,539,223. On average, 2 Wall Street analysts forecast IVF's revenue for 2027 to be $29,694,618, with the lowest IVF revenue forecast at $28,812,317, and the highest IVF revenue forecast at $30,869,829.
In 2028, IVF is forecast to generate $46,917,353 in revenue, with the lowest revenue forecast at $45,524,246 and the highest revenue forecast at $48,774,830.